期刊文献+

Carbohydrate Antigens as Potential Biomarkers for the Malignancy in Patients with Idiopathic Deep Venous Thrombosis:A Retrospective Cohort Study

Carbohydrate Antigens as Potential Biomarkers for the Malignancy in Patients with Idiopathic Deep Venous Thrombosis: A Retrospective Cohort Study
下载PDF
导出
摘要 A variety of biomarkers have been identified in recent prospective and retrospective re- ports as being potentially predictive of venous thromboembolis (VTE), particularly idiopathic deep venous thrombosis (IDVT). This study identified a serum tumor biomarker for early screening of IDVT. A total of 128 IDVT patients (54 females and 74 males; average age: 50.9+17.4 years) were included. Carcinoembryonic antigen (CEA), ferritin, β2-microglobulin, cancer antigen (CA) 125, CA 15-3, CA 19-9, squamous cell carcinoma antigen (SCC), alpha-fetoprotein (AFP), prostate specific antigen (PSA), free PSA (f-PSA), and beta-human chorionic gonadotropin (13-HCG) in patients with IDVT were detected. Malignancies were histo- or cytopathologically confirmed. Of the 128 IDVT patients, 16 (12.5%) were found to have malignarteies. Serum CEA, CA 125, CA 15-3, and CA 19-9 were found to be helpful for detecting malignancies in IDVT patients. Our study revealed a positive association between these markers and tumors in IDVT patients. On the other hand, SCC and AFP were not sensitive enough to be markers for detecting tumors in patients with IDVT. No significant differences were found in positive rates of ferritin and 132-microglobulin between turnor and non-ttmaor groups, and no significant difference exists in serum levels of ferritin and 132-microglobulin between the two groups. Carbohydrate antigens, CA 15-3 in particular, may be useful for differential diagnosis and prediction of malignancies in patients with IDVT. A variety of biomarkers have been identified in recent prospective and retrospective re- ports as being potentially predictive of venous thromboembolis (VTE), particularly idiopathic deep venous thrombosis (IDVT). This study identified a serum tumor biomarker for early screening of IDVT. A total of 128 IDVT patients (54 females and 74 males; average age: 50.9+17.4 years) were included. Carcinoembryonic antigen (CEA), ferritin, β2-microglobulin, cancer antigen (CA) 125, CA 15-3, CA 19-9, squamous cell carcinoma antigen (SCC), alpha-fetoprotein (AFP), prostate specific antigen (PSA), free PSA (f-PSA), and beta-human chorionic gonadotropin (13-HCG) in patients with IDVT were detected. Malignancies were histo- or cytopathologically confirmed. Of the 128 IDVT patients, 16 (12.5%) were found to have malignarteies. Serum CEA, CA 125, CA 15-3, and CA 19-9 were found to be helpful for detecting malignancies in IDVT patients. Our study revealed a positive association between these markers and tumors in IDVT patients. On the other hand, SCC and AFP were not sensitive enough to be markers for detecting tumors in patients with IDVT. No significant differences were found in positive rates of ferritin and 132-microglobulin between turnor and non-ttmaor groups, and no significant difference exists in serum levels of ferritin and 132-microglobulin between the two groups. Carbohydrate antigens, CA 15-3 in particular, may be useful for differential diagnosis and prediction of malignancies in patients with IDVT.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2014年第5期722-728,共7页 华中科技大学学报(医学英德文版)
关键词 biomarkers CANCER deep vein thrombosis idiopathic deep venous thrombosis carbohydrate antigen biomarkers cancer deep vein thrombosis idiopathic deep venous thrombosis carbohydrate antigen
  • 相关文献

参考文献46

  • 1Trousseau A.Phlegmasia Alba Dolens.2nd ed.Clinique Médicale de l'Hotel Dieu de Paris,Vol.3.Pads:JB Baillère,1865,659-712.
  • 2Billroth T.Lectures on surgical pathology and therapeutics:a handbook for students and practitioners.8th ed.London:The New Sydenham Society,1878,1877-1878.
  • 3Sack GH Jr,Levin J,Bell WR.Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms:clinical,pathophysiologic,and therapeutic features.Medicine,1977,56(1):1-37.
  • 4Lip GY,Chin BS,Blann AD.Cancer and the prothrombotic state.Lancet Oncol,2002,3(1):27-34.
  • 5Rickles FR,Levine M,Edwards RL.Hemostatic alterations in cancer patients.Cancer Metastasis Rev,1992,11(3-4):237-248.
  • 6Khorana AA,Francis CW,Culakova E,et al.Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.J Thromb Haemost,2007,5(3):632-634.
  • 7Falanga A,Zacharski L.Deep vein thrombosis in cancer:the scale of the problem and approaches to management.Ann Oncol,2005,16(5):696-701.
  • 8Prandoni P,Lensing AW,Cogo A,et al.The long-term clinical course of acute deep vein thrombosis.Ann Intern Med,1996,125(1):1-7.
  • 9Sφrensen HT,Mellemkjaer L,Olsen JH,et al.Prognosis of cancer associated with venous thromboembolism.N Engl J Med,2000,343(25):1846-1850.
  • 10Seddighzadeh A,Shetty R,Goldhaber SZ.Venous thromboembolism in patients with active cancer.Thromb Haemost,2007,98(3):656-661.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部